MEDNAX, INC. 4
4 · MEDNAX, INC. · Filed Jun 2, 2017
Insider Transaction Report
Form 4
Clark David A.
COO / Pediatrix Division
Transactions
- Award
Common Stock
2017-06-01+15,277→ 35,302 total - Sale
Common Stock
2017-06-01$54.99/sh−10,202$561,041→ 25,100 total
Footnotes (3)
- [F1]Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.
- [F2]Sales made pursuant to Reporting Person's 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in fifty-three (53) separate transactions with prices ranging from $54.16 to $55.39 for an average weighted sales price of $54.9932. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.